InspireMD- Warrants Profit Margin

InspireMD- Warrants (NSPRZ) currently reports a profit margin of -415.7% as of December 2025. That compares with -335.9% in the prior-year period — down 23.8% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore InspireMD- Warrants's profit margin history and peer comparisons.

InspireMD- Warrants's profit margin decreased from -335.9% to -415.7% — a 23.8% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

InspireMD- Warrants's profit margin of -415.7% is lower than the Healthcare sector average of 13.76%. That is roughly 3121.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but InspireMD- Warrants's current -415.7% should be judged against Healthcare norms (sector average: 13.76%) and against NSPRZ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -415.7%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for InspireMD- Warrants, and consider following NSPRZ for alerts when major investors trade the stock.